Côd QR

Eravacycline for Mycobacterium abscessus infections: pharmacodynamic advantages of long-acting post-antibiotic effects and weekly dosing regimens

ABSTRACT Mycobacterium abscessus (MAB) is one of the most common non-tuberculous mycobacteria with an extremely high resistance rate to classic anti-tuberculosis drugs. This study aimed to evaluate the activities of the novel tetracycline agent eravacycline (ERC) against MAB using clinical isolates...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Ruoyan Ying, Guoling Yang, Xiaochen Huang, Jie Wang, Li Wang, Wei Sha
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society for Microbiology 2026-05-01
Cyfres:Microbiology Spectrum
Pynciau:
Mycobacterium abscessus
eravacycline
PAE
PA-SME
pulmonary infection
Mynediad Ar-lein:https://journals.asm.org/doi/10.1128/spectrum.01473-25
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg